Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability-Reference-Cited by-同舟云学术

Development of small-molecule Tau-SH3 interaction inhibitors that prevent amyloid-β toxicity and network hyperexcitability

Published:2024-01 Issue:1 Volume:21 Page:e00291
ISSN:1878-7479
Container-title:Neurotherapeutics
language:en
Short-container-title:Neurotherapeutics

Author:

Roth Jonathan R.,Rush Travis,Thompson Samantha J.,Aldaher Adam R.,Dunn Trae B.,Mesina Jacob S.,Cochran J. Nicholas,Boyle Nicholas R.,Dean Hunter B.,Yang Zhengrong,Pathak Vibha,Ruiz Pedro,Wu Mousheng,Day Jeremy J.,Bostwick J. Robert,Suto Mark J.,Augelli-Szafran Corinne E.,Roberson Erik D.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Reference68 articles.

1. Tau is essential to β-amyloid-induced neurotoxicity;Rapoport;Proc Natl Acad Sci USA,2002

2. Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model;Roberson;Science,2007

3. Dendritic function of tau mediates amyloid-β toxicity in Alzheimer's disease mouse models;Ittner;Cell,2010

4. Amyloid-beta/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease;Roberson;J Neurosci,2011

5. Lack of tau proteins rescues neuronal cell death and decreases amyloidogenic processing of APP in APP/PS1 mice;Leroy;Am J Pathol,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fyn Kinase in Alzheimer’s Disease: Unraveling Molecular Mechanisms and Therapeutic Implications;Molecular Neurobiology;2024-06-18

2. Genetic forms of tauopathies: inherited causes and implications of Alzheimer’s disease-like TAU pathology in primary and secondary tauopathies;Journal of Neurology;2024-03-30

3. Disentangling tau: One protein, many therapeutic approaches;Neurotherapeutics;2024-01